| Application no. and date | 21726426.6 (espacenet) (Federated) (European Patent Register), 20210524 | | Patent/reg. no. and date | DK/EP 4153232, 20240626 | | Publication date | 20230329 | | Priority no. and date | EP 20176157, 20200522 | | EP pub. no. and date |
EP 4153232 20230329 | | Effective date | | | Applicant/owner | Philogen S.p.A., La Lizza 7
53100 Siena, IT | | Applicant ref. no. | V478934DK00 | | Inventor | HEMMERLE, Theresa,
8112 Otelfingen, CH | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/175 (2006.01) , A61K 31/495 (2006.01) , A61K 38/19 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 14/525 (2006.01) , C07K 16/18 (2006.01) | | Title | TNFalfa-immunkonjugatterapi til behandling af hjernetumorer | | Int. application no. | EP2021063758 | | Int. publication no. | WO2021234178 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
